Stuart MacLeod

3.1k total citations
115 papers, 2.1k citations indexed

About

Stuart MacLeod is a scholar working on Pediatrics, Perinatology and Child Health, Economics and Econometrics and General Health Professions. According to data from OpenAlex, Stuart MacLeod has authored 115 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 58 papers in Pediatrics, Perinatology and Child Health, 27 papers in Economics and Econometrics and 20 papers in General Health Professions. Recurrent topics in Stuart MacLeod's work include Pharmaceutical studies and practices (42 papers), Pharmaceutical Economics and Policy (17 papers) and Antibiotics Pharmacokinetics and Efficacy (15 papers). Stuart MacLeod is often cited by papers focused on Pharmaceutical studies and practices (42 papers), Pharmaceutical Economics and Policy (17 papers) and Antibiotics Pharmacokinetics and Efficacy (15 papers). Stuart MacLeod collaborates with scholars based in Canada, United States and United Kingdom. Stuart MacLeod's co-authors include Gideon Koren, Alan Isles, Michael Spino, Jake J. Thiessen, Henry Levison, Steven J. Soldin, Christopher J. L. Newth, Elvan Tabachnik, Helen S. L. Chan and Ronald Gold and has published in prestigious journals such as PLoS ONE, Neurology and American Journal of Respiratory and Critical Care Medicine.

In The Last Decade

Stuart MacLeod

113 papers receiving 1.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Stuart MacLeod Canada 27 715 423 400 231 212 115 2.1k
Mette Madsen Denmark 31 310 0.4× 191 0.5× 476 1.2× 254 1.1× 268 1.3× 73 3.9k
James McCormack Canada 27 250 0.3× 229 0.5× 367 0.9× 313 1.4× 220 1.0× 102 2.1k
J. R. B. J. Brouwers Netherlands 39 527 0.7× 173 0.4× 551 1.4× 194 0.8× 370 1.7× 196 4.5k
Edward P. Armstrong United States 27 345 0.5× 245 0.6× 171 0.4× 319 1.4× 363 1.7× 149 2.9k
Xavier Kurz Netherlands 31 226 0.3× 563 1.3× 390 1.0× 173 0.7× 520 2.5× 92 3.5k
Haleh Bagheri France 31 373 0.5× 169 0.4× 479 1.2× 76 0.3× 184 0.9× 176 3.0k
Peter H. Vlasses United States 28 307 0.4× 227 0.5× 359 0.9× 151 0.7× 185 0.9× 176 2.9k
Arturo Cuomo Italy 25 259 0.4× 379 0.9× 233 0.6× 141 0.6× 169 0.8× 88 3.7k
Matitiahu Berkovitch Israel 30 928 1.3× 284 0.7× 389 1.0× 128 0.6× 65 0.3× 184 3.3k
Antje Neubert Germany 30 1.5k 2.0× 133 0.3× 268 0.7× 377 1.6× 357 1.7× 100 2.4k

Countries citing papers authored by Stuart MacLeod

Since Specialization
Citations

This map shows the geographic impact of Stuart MacLeod's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stuart MacLeod with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stuart MacLeod more than expected).

Fields of papers citing papers by Stuart MacLeod

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stuart MacLeod. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stuart MacLeod. The network helps show where Stuart MacLeod may publish in the future.

Co-authorship network of co-authors of Stuart MacLeod

This figure shows the co-authorship network connecting the top 25 collaborators of Stuart MacLeod. A scholar is included among the top collaborators of Stuart MacLeod based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stuart MacLeod. Stuart MacLeod is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
MacLeod, Stuart, Paul Lasko, & Alex MacKenzie. (2014). The study of drugs for rare disorders: harnessing research contributions by Canadian academic institutions.. PubMed. 21(1). e47–55. 2 indexed citations
2.
Wiens, Matthew O., et al.. (2014). Post-market drug evaluation research training capacity in Canada: an environmental scan of Canadian educational institutions.. PubMed. 21(3). e370–8. 3 indexed citations
3.
MacLeod, Stuart. (2014). Canada's Progress Toward an Orphan Drug Framework: 2014. 21(1). 2 indexed citations
4.
Mugyenyi, Godfrey, Joseph Ngonzi, Stuart MacLeod, et al.. (2013). Alcohol exposure among pregnant women in sub-saharan Africa: a systematic review.. PubMed. 20(3). e321–33. 25 indexed citations
5.
Puterman, Martin L., Yue Zhang, Sema K. Aydede, et al.. (2012). 'If You're Not Keeping Score, You're Just Practicing': A Lean Health Care Program Evaluation Framework. SSRN Electronic Journal. 2 indexed citations
6.
Zhang, Tingting, et al.. (2012). Prescription drug dispensing profiles for one million children: a population-based analysis. European Journal of Clinical Pharmacology. 69(3). 581–588. 37 indexed citations
7.
MacLeod, Stuart. (2011). The plight of paediatric drug therapy. Paediatrics & Child Health. 16(9). 529–531. 3 indexed citations
8.
MacLeod, Stuart. (2009). Improving Drug Treatment for Children. Pediatric Drugs. 11(1). 1–3. 2 indexed citations
9.
Marshall, Deborah A., et al.. (2008). Guidelines for Conducting Pharmaceutical Budget Impact Analyses for Submission to Public Drug Plans in Canada. PharmacoEconomics. 26(6). 477–495. 58 indexed citations
10.
Marshall, Deborah A., et al.. (2004). Resistance to antibiotics: administrative response to the challenge.. PubMed. 17(12). 20–9. 3 indexed citations
11.
Labiris, N. R., Anne Holbrook, Henry Chrystyn, Stuart MacLeod, & Michael T. Newhouse. (1999). Dry Powder versus Intravenous and Nebulized Gentamicin in Cystic Fibrosis and Bronchiectasis: A Pilot Study. American Journal of Respiratory and Critical Care Medicine. 160(5). 1711–1716. 61 indexed citations
12.
Pellegrini, Elizabeth, et al.. (1989). Determinants of recall and recall bias in studying drug and chemical exposure in pregnancy. Teratology. 40(1). 37–45. 89 indexed citations
13.
Chan, Helen S. L., et al.. (1987). Nabilone Versus Prochlorperazine for Control of Cancer Chemotherapy-Induced Emesis in Children: A Double-Blind, Crossover Trial. PEDIATRICS. 79(6). 946–952. 74 indexed citations
14.
Spino, Michael, Alan Isles, J. Williamson Balfe, et al.. (1985). Assessment of glomerular filtration rate and effective renal plasma flow in cystic fibrosis. The Journal of Pediatrics. 107(1). 64–70. 37 indexed citations
15.
Koren, Gideon, Peter S. Hesslein, & Stuart MacLeod. (1984). Digoxin toxicity associated with amiodarone therapy in children. The Journal of Pediatrics. 104(3). 467–470. 20 indexed citations
16.
Koren, Gideon & Stuart MacLeod. (1984). Difficulty in achieving therapeutic serum concentrations of salicylate in Kawasaki disease. The Journal of Pediatrics. 105(6). 991–995. 25 indexed citations
17.
Tabachnik, Elvan, Peter Scott, Alan Isles, et al.. (1982). Sustained-release theophylline: A significant advance in the treatment of childhood asthma. The Journal of Pediatrics. 100(3). 489–492. 61 indexed citations
18.
Scott, P., et al.. (1981). Sustained-release theophylline for childhood asthma: Evidence for circadian variation of theophylline pharmacokinetics. The Journal of Pediatrics. 99(3). 476–479. 106 indexed citations
19.
Radde, I. C., et al.. (1981). Influence of specific gravity on intravenous drug delivery. The Journal of Pediatrics. 99(4). 658–661. 13 indexed citations
20.
Aranda, Jacob V., Stuart MacLeod, Kenneth W. Renton, & Norman R. Eade. (1974). Hepatic microsomal drug oxidation and electron transport in newborn infants. The Journal of Pediatrics. 85(4). 534–542. 45 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Mette Madsen Breakdown of academic impact, for papers by James McCormack Breakdown of academic impact, for papers by J. R. B. J. Brouwers Breakdown of academic impact, for papers by Edward P. Armstrong Breakdown of academic impact, for papers by Xavier Kurz Breakdown of academic impact, for papers by Haleh Bagheri Breakdown of academic impact, for papers by Peter H. Vlasses Breakdown of academic impact, for papers by Arturo Cuomo Breakdown of academic impact, for papers by Matitiahu Berkovitch Breakdown of academic impact, for papers by Antje Neubert
Rankless by CCL
2026